CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), is set to launch their new line of CBD PM Softgel Capsules in conjunction with World Sleep Day (March 13). Utilizing their unique Superior Broad Spectrum formula, cbdMD’s latest offering includes the same proprietary sleep formula with ingredients like melatonin, chamomile, valerian root, and more.
CBD PM Softgel Capsules use the same high-quality ingredients as their original CBD PM Tinctures, but in gel capsule form. This launch comes on the heels of the one-year anniversary of cbdMD's launch of their original CBD PM tincture product – winner of the 2020 Product of the Year for CBD Sleep Aids.1
CBD PM Softgel Capsules contain 16.5 mg of superior CBD plus 3 mg of melatonin per capsule, and are available in 30- and 60-count bottles. The new product also contains a proprietary blend of soothing botanicals and utilizes gelatin capsules containing MCT oil as an active carrier for all ingredients.
As a part of National Sleep Month, cbdMD has also launched a "Sleep Better" campaign to highlight the issues that keep millions of Americans up at night.
Along with showcasing products for sleep and relaxation, the Sleep Better campaign features educational materials for people from various walks of life – ranging from seniors and harried parents to young professionals and athletes on the go.
According to the Centers for Disease Control, 100 million U.S. adults get inadequate sleep. To compound matters, March is when citizens of most states “spring forward” and lose an hour, a disruption of the normal rhythm that can disturb even normally sound sleepers.
“Healthy sleep habits are an essential part of living everyday to the fullest. Unfortunately, it’s one of several wellness topics that simply doesn’t get enough attention,” said Caryn Dunayer, President and Co-founder of cbdMD. “With the launch of CBD PM Softgel Capsules and our Sleep Better campaign, we hope to strengthen education while providing practical solutions to common everyday challenges.”
cbdMD’s Superior Broad Spectrum products are available to consumers at the company’s retail website, www.cbdMD.com.
New wholesale customers can make inquiries through the cbdMD wholesale page. Current wholesale account holders may make purchases through regular channels.
cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA, Life Time, Inc., and Supercross, and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of THC-free* superior CBD products, please visit www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one of the 4,000 retail outlets that carry cbdMD products.
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ″should,″ ″may,″ ″intends,″ ″anticipates,″ ″believes,″ ″estimates,″ ″projects,″ ″forecasts,″ ″expects,″ ″plans,″ and ″proposes.″ These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the Securities and Exchange Commission (the "SEC"), and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
*THC-free is defined as below the level of detection using valid scientific analytical tools.
1Survey of 40,000 people by Kantar. Winner: CBD Sleep Aid